טוען...
Natural Killer cell control of BRAF(V600E) mutant melanoma during targeted therapy
Pharmacologic inhibition of the mutant BRAF(V600E) protein in advanced BRAF(V600E) melanoma results in a high proportion of patients that respond, but few with durable responses. We have recently revealed that Natural Killer (NK) cells play an essential role in the BRAF(V600E) inhibitor control of m...
שמור ב:
| הוצא לאור ב: | Oncoimmunology |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485837/ https://ncbi.nlm.nih.gov/pubmed/26137412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2014.998119 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|